Bart Filius
Directeur/Membre du Conseil chez PROQR THERAPEUTICS N.V.
Fortune : - $ au 30/04/2024
Postes actifs de Bart Filius
Sociétés | Poste | Début | Fin |
---|---|---|---|
PROQR THERAPEUTICS N.V. | Directeur/Membre du Conseil | 21/05/2019 | - |
Independent Dir/Board Member | 21/05/2019 | - | |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Bart Filius
Anciens postes connus de Bart Filius
Sociétés | Poste | Début | Fin |
---|---|---|---|
GALAPAGOS NV | Directeur des opérations | 01/09/2017 | 30/06/2023 |
Directeur Financier/CFO | 01/12/2014 | 30/06/2023 | |
President | 01/02/2021 | 30/06/2023 | |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Part of Sanofi, Sanofi European Treasury Center SA provides financial services. The private company is based in Brussels, Belgium. | Directeur Financier/CFO | 01/03/2012 | 01/12/2014 |
sanofi-aventis Netherlands BV | Directeur Financier/CFO | 01/09/2005 | 01/03/2012 |
Corporate Officer/Principal | 01/01/2001 | 01/03/2012 |
Formation de Bart Filius
Nyenrode Business Universiteit | Undergraduate Degree |
INSEAD | Masters Business Admin |
Statistiques
Internationale
Pays-Bas | 4 |
Belgique | 3 |
Royaume-Uni | 2 |
Opérationnelle
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
GALAPAGOS NV | Health Technology |
PROQR THERAPEUTICS N.V. | Health Technology |
Entreprise privées | 3 |
---|---|
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
sanofi-aventis Netherlands BV | |
Sanofi European Treasury Center SA
Sanofi European Treasury Center SA Financial ConglomeratesFinance Part of Sanofi, Sanofi European Treasury Center SA provides financial services. The private company is based in Brussels, Belgium. | Finance |
- Bourse
- Insiders
- Bart Filius
- Expérience